|
|
|
13:00 – 14:30 |
|
|
|
|
|
Ball Room B |
||
Ball Room C |
||
14:30 – 15:00 |
Coffee break |
|
15:00 – 16:30 |
|
|
|
|
|
Ball Room A |
||
Ball Room B |
||
Ball Room C |
||
P. Sachsen-Coburg V |
||
16:30 – 17:00 |
Coffee break |
|
17:00 – 18:30 |
|
|
Ball Room B |
||
Ball Room C |
||
P. Sachsen-Coburg V | ||
|
|
|
Cardiovascular Medicine – Introduction of a Center |
||
08:00 – 08:45 |
Cardiovascular Medicine – Symposium Opening |
|
08:00 – 08:15 |
CCVM WelcomeChair: C. Hengstenberg, G. Laufer |
|
08:15 – 08:45 |
Keynote Lecture: Inflammation and Atherosclerosis |
P. Libby |
|
|
|
|
HEART TEAM – Aortic Valve Chair: M. Andreas, H. FigullaPanel: M. Glauber, M. Grimm, M. Haude, T. Modine |
|
08:45 – 12:30 |
Live case I: Aortic Valve – TAVI (Interventional) |
|
|
||
08:45 – 12:30 |
Live case II: Aortic Valve (Surgical) |
|
|
|
|
09:45 – 10:00 |
Treatment of Aortic Stenosis – Current Guidelines |
H. Baumgartner |
|
|
|
10:00 – 10:30 |
Coffee Break |
|
|
|
|
10:30 – 12:30 |
Aortic Valve Interventions Chair: M. Andreas, H. Figulla |
|
10:30 – 10:45 |
TAVI – Progress, Pseudoprogress and Future Directions |
S. Kodali |
10:45 – 11:00 |
SAVR – Progress, Pseudoprogress and Future Directions |
M. Glauber |
11:00 – 11:15 |
TAVR in Aortic Regurgitation |
H. Figulla |
11:15 – 12:00 |
Live case III: Aortic Valve – TAVI (Interventional) |
|
12:00 – 12:15 |
Antithrombotic Management after TAVR/SAVR |
L. Sondergaard |
|
|
|
12:15 – 12:30 |
Wrap-up Live Cases |
|
|
|
|
12:30 – 14:00 |
Lunch |
|
|
|
|
12:45 – 13:45 |
Lunch Symposium |
|
|
HEART TEAM – Mitral Valve Chair: C. Hengstenberg, H. ReichenspurnerPanel: L. Müller, R. Seitelberger, A. Vahanian, A. Zirlik |
|
14:00 – 14:20 |
Outcome Variables in Heart Failure |
G. Laufer |
|
||
14:20 – 18:30 |
Live case IV: Mitral Valve (Interventional) |
|
14:20 – 18:30 |
Live case V: Mitral Valve (Surgical) |
|
|
|
|
15:00 – 16:30 |
Functional Mitral Regurgitation Chair: C. Hengstenberg, H. ReichenspurnerPanel: L. Müller, R. Seitelberger, A. Vahanian, A. Zirlik |
|
15:00 – 15:15 |
FMR – Pathophysiology and Clinical Significance |
N. Wunderlich |
15:15 – 15:30 |
Outcome with OMT and Traditional Surgical Techniques |
R. Rosenhek |
15:30 – 15:45 |
FMR Transcatheter Procedures – COAPT |
A. Zirlik |
15:45 – 16:00 |
FMR Transcatheter Procedures – MITRA-FR |
A. Vahanian |
16:00 – 16:15 |
COAPT / MITRA-FR: Critical Review of Statistics |
N. Freemantle |
16:15 – 16:30 |
Future Surgical Options: Ventricular Remodelling and beyond |
H. Reichenspurner |
16:30 – 17:00 |
Coffee Break |
|
|
|
|
17:00 – 18:30 |
Reality Check: Future Treatment Options in Mitral Valve Disease Chair: G. Maurer, F. WeidingerPanel: S. Benussi, R. K. Binder, R. Lange, N. Van Mieghem |
|
17:00 – 17:20 |
Transcatheter MV Repair |
F. Kreidel |
17:20 – 17:35 |
Unmet Clinical Need in MV Disease |
E. Grube |
17:35 – 17:50 |
Transcatheter MV Replacement |
R. Lange |
17:50 – 18:10 |
Atrial Ablation and LAA Management |
S. Benussi |
18:10 – 18:30 |
Transapical Beating Heart MV Repair |
A. Colli |
|
|
|
18:30 – 18:45 |
Wrap-Up Live Cases |
|
|
|
|
|
|
|
|
|
|
HEART TEAM – Coronary Artery Disease |
|
08:30 – 09:30 |
The Atherosclerotic Plaque – Genesis and Prevention Chair: P. Libby, J. WojtaPanel: C. Binder, M. V. Ezhov, W. Koenig, A. Podczeck-Schweighofer |
|
08:30 – 08:50 |
BASIC SCIENCE KEYNOTE LECTUREInflammatory Concepts in Vascular Disease |
C. Binder |
|
|
|
08:50 – 09:05 |
Lipid managment in CAD – the Lower the Better / PRO |
W. Koenig |
|
|
|
09:05 – 09:15 |
Lipid managment in CAD – the Lower the Better / CONTRA |
H. Drexel |
|
|
|
09:15 – 09:30 |
Compromise: Case Presentation CAD Plaque and OCT + Panel Discussion |
L. Räber |
09:30 – 10:15 |
Live Case VI: Coronary Revascularization (Interventional) |
|
10:15 – 10:45 |
Coffee Break |
|
|
|
|
10:45 – 12:00 |
Coronary Revascularization Chair: G. Laufer, R. Mehran Panel: N. Bonaros, A. Böning, P. W. Serruys, N. Van Mieghem |
|
10:45 – 11:15 |
Tailor-made Decision making for Surgical or Percutaneous Revascularization based on Non-Invasive Imaging and Comorbidities |
P. W. Serruys |
|
||
11:15 – 12:00 |
Live Case VII: Coronary Revascularization (Surgical) |
|
12:00 – 13:00 |
Lunch |
|
|
|
|
12:00 – 13:00 |
Lunch Symposium |
|
13:00 – 14:30 |
PRO/CON Debate – Revascularization Chair: I. Lang, S. SandnerPanel: O. Dapunt, R. Mehran, T. Neunteufl, A. Zierer |
|
|
||
13:00 – 13:15 |
ORBITA – Trial Revisited: What to learn |
R. Mehran |
|
|
|
13:15 – 13:30 |
Patients with LM/3VD should undergo PCI |
N. Van Mieghem |
13:30 – 13:45 |
Patients with LM/3VD should undergo CABG |
N. Bonaros |
|
|
|
13:45 – 14:00 |
FFR guided Revascularization – PRO and CON |
G. Toth |
|
|
|
14:00 – 14:15 |
Paradise Lost – the Role of Scaffolds in Clinical Practice |
A. Kastrati |
|
|
|
14:15 – 14:30 |
Pro/Con Discussion |
|
14:30 – 15:00 |
Coffee Break |
|
15:00 – 16:15 |
Reality check Lectures: Progress in Coronary Revascularisation Chair: A. Böning, P.W. SerruysPanel: G. Delle Karth, K. Kozuma, B. Meier, S. Sandner |
|
|
||
15:00 – 15:15 |
Current Study Results and Sub-Group Analysis on FFR and iFR and its Implication on Routine Measurement |
H. Post |
15:15 – 15:30 |
Innovations in PCI: A Reality Check |
M. Haude |
|
|
|
15:30 – 15:45 |
Innovations in CABG: A Reality Check |
A. Böning |
|
|
|
15:45 – 16:05 |
Past, Present & Future Perspectives in Coronary Revascularization |
B. Meier |
|
|
|
16:05 – 16:15 |
Wrap-up Live Cases |
|
|
|
|
16:15 – 16:30 | Farewell Ceremony |
G. LauferC. Hengstenberg |